{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:47:55Z","timestamp":1792198075097,"version":"4.4.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["NEMI (184.034.014)"],"award-info":[{"award-number":["NEMI (184.034.014)"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Infections with antimicrobial resistant pathogens are a major threat to human health. Inhibitors of the replicative polymerase PolC are a promising novel class of antimicrobials against Gram-positive pathogens, but the structural basis for their activity remains unknown. The first-in-class PolC-targeting antimicrobial, ibezapolstat, is a guanine analogue in late-stage clinical development for the treatment of\n                    <jats:italic>Clostridioides difficile<\/jats:italic>\n                    infections, and related inhibitors are being developed for systemic treatment of infections with methicillin-resistant\n                    <jats:italic>Staphylococcus aureus<\/jats:italic>\n                    (MRSA) and vancomycin-resistant enterococci (VRE). Here, we present the cryo-electron microscopy structures of\n                    <jats:italic>Enterococcus faecium<\/jats:italic>\n                    PolC bound to DNA and in complex with ibezapolstat or the previously-undescribed inhibitor ACX-801. Both inhibitors form base-pairing interactions with the DNA in the active site, thereby competing with incoming dGTP nucleotides. We identify a crucial susceptibility determinant in PolC that is conserved in other organisms, such as\n                    <jats:italic>C. difficile<\/jats:italic>\n                    . This is explained by an unusual non-planar conformation of the inhibitors that induce a binding pocket in PolC. By combining structural, biochemical, bioinformatic and genetic analyses, this work lays the foundation for the rational development of an innovative class of antimicrobials against Gram-positive priority pathogens.\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-65324-8","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T10:14:29Z","timestamp":1762424069000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A unique inhibitor conformation selectively targets the DNA polymerase PolC of Gram-positive priority pathogens"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8259-3991","authenticated-orcid":false,"given":"Mia","family":"Urem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke H.","family":"Friggen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8713-0888","authenticated-orcid":false,"given":"Nina","family":"Musch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6651-646X","authenticated-orcid":false,"given":"Michael H.","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9636-4567","authenticated-orcid":false,"given":"Christopher J.","family":"Swain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Barbachyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7653-4135","authenticated-orcid":false,"given":"Lawrence I.","family":"Mortin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0802-2151","authenticated-orcid":false,"given":"Robert J.","family":"DeLuccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4205-1338","authenticated-orcid":false,"given":"Meindert H.","family":"Lamers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7409-2847","authenticated-orcid":false,"given":"Wiep Klaas","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"65324_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"Antimicrobial Resistance Collaborators.","year":"2022","unstructured":"Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet 399, 629\u2013655 (2022).","journal-title":"Lancet"},{"key":"65324_CR2","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","volume":"404","author":"GBD 2021 Antimicrobial Resistance Collaborators.","year":"2024","unstructured":"GBD 2021 Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance 1990\u20132021: A systematic analysis with forecasts to 2050. Lancet 404, 1199\u20131226 (2024).","journal-title":"Lancet"},{"key":"65324_CR3","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa1914433","volume":"382","author":"JA Jernigan","year":"2020","unstructured":"Jernigan, J. A. et al. Multidrug-resistant bacterial infections in U.S. hospitalized patients, 2012\u20132017. N. Engl. J. Med. 382, 1309\u20131319 (2020).","journal-title":"N. Engl. J. Med."},{"key":"65324_CR4","doi-asserted-by":"crossref","unstructured":"Theuretzbacher, U., Jumde, R. P., Hennessy, A., Cohn, J. & Piddock, L. J. V. Global health perspectives on antibacterial drug discovery and the preclinical pipeline. Nat. Rev. Microbiol. 23, 474\u2013449 (2025).","DOI":"10.1038\/s41579-025-01167-w"},{"key":"65324_CR5","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.cell.2006.07.027","volume":"126","author":"S Bailey","year":"2006","unstructured":"Bailey, S., Wing, R. A. & Steitz, T. A. The Structure of T. aquaticus DNA polymerase III is distinct from eukaryotic replicative DNA polymerases. Cell 126, 893\u2013904 (2006).","journal-title":"Cell"},{"key":"65324_CR6","doi-asserted-by":"publisher","first-page":"20695","DOI":"10.1073\/pnas.0809989106","volume":"105","author":"RJ Evans","year":"2008","unstructured":"Evans, R. J. et al. Structure of PolC reveals unique DNA binding and fidelity determinants. Proc. Natl. Acad. Sci. 105, 20695\u201320700 (2008).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"65324_CR7","first-page":"1275","volume":"72","author":"E van Eijk","year":"2017","unstructured":"van Eijk, E., Wittekoek, B., Kuijper, E. J. & Smits, W. K. DNA replication proteins as potential targets for antimicrobials in drug-resistant bacterial pathogens. J. Antimicrob. Chemother. 72, 1275\u20131284 (2017).","journal-title":"J. Antimicrob. Chemother."},{"key":"65324_CR8","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3390\/antibiotics9110776","volume":"9","author":"JA Santos","year":"2020","unstructured":"Santos, J. A. & Lamers, M. H. Novel antibiotics targeting bacterial replicative DNA polymerases. Antibiotics 9, 776 (2020).","journal-title":"Antibiotics"},{"key":"65324_CR9","doi-asserted-by":"publisher","first-page":"6373","DOI":"10.3390\/ijms23126373","volume":"23","author":"AA Kuznetsova","year":"2022","unstructured":"Kuznetsova, A. A., Fedorova, O. S. & Kuznetsov, N. A. Structural and molecular kinetic features of activities of DNA polymerases. Int. J. Mol. Sci. 23, 6373 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"65324_CR10","doi-asserted-by":"publisher","first-page":"20565","DOI":"10.1073\/pnas.0811279106","volume":"105","author":"MH Lamers","year":"2008","unstructured":"Lamers, M. H. & O\u2019Donnell, M. A consensus view of DNA binding by the C family of replicative DNA polymerases. Proc. Natl. Acad. Sci. 105, 20565\u201320566 (2008).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"65324_CR11","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1093\/nar\/gkt900","volume":"42","author":"K Timinskas","year":"2014","unstructured":"Timinskas, K., Balvociute, M., Timinskas, A. & Venclovas, C. Comprehensive analysis of DNA polymerase III alpha subunits and their homologs in bacterial genomes. Nucleic Acids Res. 42, 1393\u20131413 (2014).","journal-title":"Nucleic Acids Res"},{"key":"65324_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.molcel.2009.12.025","volume":"37","author":"GM Sanders","year":"2010","unstructured":"Sanders, G. M., Dallmann, H. G. & McHenry, C. S. Reconstitution of the B. subtilis replisome with 13 proteins including two distinct replicases. Mol. Cell 37, 273\u2013281 (2010).","journal-title":"Mol. Cell"},{"key":"65324_CR13","doi-asserted-by":"publisher","first-page":"5303","DOI":"10.1093\/nar\/gkt207","volume":"41","author":"O Rannou","year":"2013","unstructured":"Rannou, O. et al. Functional interplay of DnaE polymerase, DnaG primase and DnaC helicase within a ternary complex, and primase to polymerase hand-off during lagging strand DNA replication in Bacillus subtilis. Nucleic Acids Res 41, 5303\u20135320 (2013).","journal-title":"Nucleic Acids Res"},{"key":"65324_CR14","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01604-24","volume":"69","author":"TM Wolfe","year":"2025","unstructured":"Wolfe, T. M., Jo, J., Pinkham, N. V., Garey, K. W. & Walk, S. T. The impact of ibezapolstat and other Clostridioides difficile infection-relevant antibiotics on the microbiome of humanized mice. Antimicrob. Agents Chemother. 69, e0160424 (2025).","journal-title":"Antimicrob. Agents Chemother."},{"key":"65324_CR15","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1128\/AAC.06097-11","volume":"56","author":"S Dvoskin","year":"2012","unstructured":"Dvoskin, S. et al. A novel agent effective against Clostridium difficile infection. Antimicrob. Agents Chemother. 56, 1624\u20131626 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"65324_CR16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2174\/157340811798807597","volume":"7","author":"A Torti","year":"2011","unstructured":"Torti, A. et al. Clostridium difficile DNA polymerase IIIC: Basis for activity of antibacterial compounds. Curr. Enzym Inhib. 7, 147\u2013153 (2011).","journal-title":"Curr. Enzym Inhib."},{"key":"65324_CR17","doi-asserted-by":"publisher","first-page":"e02244","DOI":"10.1128\/aac.02244-21","volume":"66","author":"J McPherson","year":"2022","unstructured":"McPherson, J. et al. Functional and metagenomic evaluation of ibezapolstat for early evaluation of anti-recurrence effects in Clostridioides difficile infection. Antimicrob. Agents Chemother. 66, e02244\u201302221 (2022).","journal-title":"Antimicrob. Agents Chemother."},{"key":"65324_CR18","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1093\/cid\/ciac096","volume":"75","author":"KW Garey","year":"2022","unstructured":"Garey, K. W. et al. Efficacy, safety, pharmacokinetics, and microbiome changes of ibezapolstat in adults with Clostridioides difficile Infection: A phase 2a multicenter clinical trial. Clin. Infect. Dis. 75, 1164\u20131170 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"65324_CR19","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1093\/jac\/dkaa364","volume":"75","author":"KW Garey","year":"2020","unstructured":"Garey, K. W. et al. A randomized, double-blind, placebo-controlled, single and multiple ascending dose Phase 1 study to determine the safety, pharmacokinetics and food and faecal microbiome effects of ibezapolstat administered orally to healthy subjects. J. Antimicrob. Chemother. 75, 3635\u20133643 (2020).","journal-title":"J. Antimicrob. Chemother."},{"key":"65324_CR20","unstructured":"Yu, X. Y., Xing, L., Wang, M., McComas, C. & Silverman, M. H. DNA polymerase IIIC inhibitors and use thereof. US Patent & Trademark Office 10723741 (2020)."},{"key":"65324_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.20","volume":"2","author":"WK Smits","year":"2016","unstructured":"Smits, W. K., Lyras, D., Lacy, D. B., Wilcox, M. H. & Kuijper, E. J. Clostridium difficile infection. Nat. Rev. Dis. Prim. 2, 16020 (2016).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"65324_CR22","unstructured":"CDC. 2019 Antibiotic Resistance Threats Report, https:\/\/www.cdc.gov\/antimicrobial-resistance\/data-research\/threats\/index.html (2019)."},{"key":"65324_CR23","doi-asserted-by":"crossref","first-page":"01363","DOI":"10.1128\/AAC.01363-18","volume":"63","author":"E van Eijk","year":"2019","unstructured":"van Eijk, E. et al. Genome location dictates the transcriptional response to PolC inhibition in Clostridium difficile. Antimicrob. Agents Chemother. 63, 01363\u201301318 (2019).","journal-title":"Antimicrob. Agents Chemother."},{"key":"65324_CR24","first-page":"2149","volume":"75","author":"B Murray","year":"2020","unstructured":"Murray, B., Wolfe, C., Marra, A., Pillar, C. & Shinabarger, D. In vitro activity of the novel antibacterial agent ibezapolstat (ACX-362E) against Clostridioides difficile. J. Antimicrob. Chemother. 75, 2149\u20132155 (2020).","journal-title":"J. Antimicrob. Chemother."},{"key":"65324_CR25","doi-asserted-by":"publisher","first-page":"e01621","DOI":"10.1128\/aac.01621-23","volume":"68","author":"E Bass\u00e8res","year":"2024","unstructured":"Bass\u00e8res, E. et al. Antibacterial activity of ibezapolstat against antimicrobial-resistant clinical strains of Clostridioides difficile. Antimicrob. Agents Chemother. 68, e01621\u2013e01623 (2024).","journal-title":"Antimicrob. Agents Chemother."},{"key":"65324_CR26","doi-asserted-by":"publisher","first-page":"7381","DOI":"10.1093\/nar\/18.24.7381","volume":"18","author":"MM Butler","year":"1990","unstructured":"Butler, M. M., Dudycz, L. W., Khan, N. N., Wright, G. E. & Brown, N. C. Development of novel inhibitor probes of DNA polymerase III based on dGTP analogs of the HPUra type: base, nucleoside and nucleotide derivatives of N2-(3,4-dichlorobenzyl)guanine. Nucleic Acids Res. 18, 7381\u20137387 (1990).","journal-title":"Nucleic Acids Res."},{"key":"65324_CR27","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.bmcl.2004.11.016","volume":"15","author":"GE Wright","year":"2005","unstructured":"Wright, G. E. et al. Active site directed inhibitors of replication-specific bacterial DNA polymerases. Bioorg. Med. Chem. Lett. 15, 729\u2013732 (2005).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"65324_CR28","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1021\/jm020591z","volume":"46","author":"C Zhi","year":"2003","unstructured":"Zhi, C. et al. Synthesis of substituted 6-anilinouracils and their inhibition of DNA polymerase IIIC and Gram-positive bacterial growth. J. Med. Chem. 46, 2731\u20132739 (2003).","journal-title":"J. Med. Chem."},{"key":"65324_CR29","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1016\/j.bmc.2019.06.017","volume":"27","author":"W-C Xu","year":"2019","unstructured":"Xu, W.-C., Silverman, M. H., Yu, X. Y., Wright, G. & Brown, N. Discovery and development of DNA polymerase IIIC inhibitors to treat Gram-positive infections. Bioorg. Med. Chem. 27, 3209\u20133217 (2019).","journal-title":"Bioorg. Med. Chem."},{"key":"65324_CR30","unstructured":"Yu, X. Y., Barbachyn, M., Swain, C. J., Mortin, L. I. & Silverman, M. H. Inhibitors of DNA Polymerase IIIC in Gram-Positive Bacteria, Pharmaceutical Compositions Thereof, and Uses Thereof. US Patent & Trademark Office, provisional patent filed (2024)."},{"key":"65324_CR31","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/emboj.2013.68","volume":"32","author":"A Toste Rego","year":"2013","unstructured":"Toste Rego, A., Holding, A. N., Kent, H. & Lamers, M. H. Architecture of the Pol III-clamp-exonuclease complex reveals key roles of the exonuclease subunit in processive DNA synthesis and repair. EMBO J. 32, 1334\u20131343 (2013).","journal-title":"EMBO J."},{"key":"65324_CR32","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.bios.2009.07.002","volume":"25","author":"C Song","year":"2009","unstructured":"Song, C., Zhang, C. & Zhao, M. Singly labeled smart probes for real-time monitoring of the kinetics of dNTP misincorporation and single nucleotide extension in DNA intra-molecular polymerization. Biosens. Bioelectron. 25, 301\u2013305 (2009).","journal-title":"Biosens. Bioelectron."},{"key":"65324_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6807-13-8","volume":"13","author":"T Barros","year":"2013","unstructured":"Barros, T. et al. A structural role for the PHP domain in E. coli DNA polymerase III. BMC Struct. Biol. 13, 8 (2013).","journal-title":"BMC Struct. Biol."},{"key":"65324_CR34","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.cell.2006.07.028","volume":"126","author":"MH Lamers","year":"2006","unstructured":"Lamers, M. H., Georgescu, R. E., Lee, S. G., O\u2019Donnell, M. & Kuriyan, J. Crystal structure of the catalytic alpha subunit of E. coli replicative DNA polymerase III. Cell 126, 881\u2013892 (2006).","journal-title":"Cell"},{"key":"65324_CR35","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1021\/acsinfecdis.1c00643","volume":"8","author":"MD Chengalroyen","year":"2022","unstructured":"Chengalroyen, M. D. et al. DNA-dependent binding of nargenicin to DnaE1 inhibits replication in Mycobacterium tuberculosis. ACS Infect. Dis. 8, 612\u2013625 (2022).","journal-title":"ACS Infect. Dis."},{"key":"65324_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00886-w","volume":"8","author":"S Ba\u00f1os-Mateos","year":"2017","unstructured":"Ba\u00f1os-Mateos, S. et al. High-fidelity DNA replication in Mycobacterium tuberculosis relies on a trinuclear zinc center. Nat. Commun. 8, 855 (2017).","journal-title":"Nat. Commun."},{"key":"65324_CR37","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1128\/AAC.46.12.3770-3775.2002","volume":"46","author":"MM Butler","year":"2002","unstructured":"Butler, M. M. et al. Low frequencies of resistance among Staphylococcus and Enterococcus species to the bactericidal DNA polymerase inhibitor N(3)-hydroxybutyl 6-(3\u2019-ethyl-4\u2019-methylanilino) uracil. Antimicrob. Agents Chemother. 46, 3770\u20133775 (2002).","journal-title":"Antimicrob. Agents Chemother."},{"key":"65324_CR38","unstructured":"Butler, M. M. Probing the dNTP Binding Region of Bacillus subtilis: DNA polymerase III with site-directed inhibitors. Ph.D. Dissertation, University of Massachusetts Medical School (1992)."},{"key":"65324_CR39","doi-asserted-by":"publisher","first-page":"e01571","DOI":"10.1128\/aac.01571-22","volume":"67","author":"R Nelson-Rigg","year":"2023","unstructured":"Nelson-Rigg, R., Fagan, S. P., Jaremko, W. J. & Pata, J. D. Pre-steady-state kinetic characterization of an antibiotic-resistant mutant of Staphylococcus aureus DNA polymerase PolC. Antimicrob. Agents Chemother. 67, e01571\u201301522 (2023).","journal-title":"Antimicrob. Agents Chemother."},{"key":"65324_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-015-1252-7","volume":"16","author":"E van Eijk","year":"2015","unstructured":"van Eijk, E. et al. Complete genome sequence of the Clostridium difficile laboratory strain 630\u0394erm reveals differences from strain 630, including translocation of the mobile element CTn5. BMC Genomics 16, 31 (2015).","journal-title":"BMC Genomics"},{"key":"65324_CR41","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1021\/acsinfecdis.4c00218","volume":"10","author":"MS Butler","year":"2024","unstructured":"Butler, M. S. et al. A review of antibacterial candidates with new modes of action. ACS Infect. Dis. 10, 3440\u20133474 (2024).","journal-title":"ACS Infect. Dis."},{"key":"65324_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115413","volume":"256","author":"F Ruggieri","year":"2023","unstructured":"Ruggieri, F. et al. Antibiotics with novel mode of action as new weapons to fight antimicrobial resistance. Eur. J. Med. Chem. 256, 115413 (2023).","journal-title":"Eur. J. Med. Chem."},{"key":"65324_CR43","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1021\/jm00219a014","volume":"20","author":"GE Wright","year":"1977","unstructured":"Wright, G. E. & Brown, N. C. Inhibitors of Bacillus subtilis DNA polymerase III. Structure-activity relations of 6-(phenylhydrazino)uracils. J. Med. Chem. 20, 1181\u20131185 (1977).","journal-title":"J. Med. Chem."},{"key":"65324_CR44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41592-021-01362-6","volume":"19","author":"J Jumper","year":"2022","unstructured":"Jumper, J. & Hassabis, D. Protein structure predictions to atomic accuracy with AlphaFold. Nat. Methods 19, 11\u201312 (2022).","journal-title":"Nat. Methods"},{"key":"65324_CR45","doi-asserted-by":"publisher","first-page":"D368","DOI":"10.1093\/nar\/gkad1011","volume":"52","author":"M Varadi","year":"2024","unstructured":"Varadi, M. et al. Alphafold protein structure database in 2024: Providing structure coverage for over 214 million protein sequences. Nucleic Acids Res. 52, D368\u2013D375 (2024).","journal-title":"Nucleic Acids Res"},{"key":"65324_CR46","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.dnarep.2015.01.012","volume":"29","author":"P Nevin","year":"2015","unstructured":"Nevin, P., Engen, J. R. & Beuning, P. J. Steric gate residues of Y-family DNA polymerases DinB and pol kappa are crucial for dNTP-induced conformational change. DNA Repair (Amst.) 29, 65\u201373 (2015).","journal-title":"DNA Repair (Amst.)"},{"key":"65324_CR47","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1093\/bib\/bbx108","volume":"20","author":"K Katoh","year":"2019","unstructured":"Katoh, K., Rozewicki, J. & Yamada, K. D. MAFFT online service: Multiple sequence alignment, interactive sequence choice and visualization. Brief. Bioinform 20, 1160\u20131166 (2019).","journal-title":"Brief. Bioinform"},{"key":"65324_CR48","doi-asserted-by":"publisher","first-page":"10881","DOI":"10.1093\/nar\/16.22.10881","volume":"16","author":"F Corpet","year":"1988","unstructured":"Corpet, F. Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res 16, 10881\u201310890 (1988).","journal-title":"Nucleic Acids Res"},{"key":"65324_CR49","doi-asserted-by":"publisher","first-page":"W299","DOI":"10.1093\/nar\/gki370","volume":"33","author":"M Landau","year":"2005","unstructured":"Landau, M. et al. ConSurf 2005: The projection of evolutionary conservation scores of residues on protein structures. Nucleic Acids Res. 33, W299\u2013W302 (2005).","journal-title":"Nucleic Acids Res."},{"key":"65324_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/pro.4582","volume":"32","author":"B Yariv","year":"2023","unstructured":"Yariv, B. et al. Using evolutionary data to make sense of macromolecules with a \u201cface-lifted\u201d ConSurf. Protein Sci. 32, e4582 (2023).","journal-title":"Protein Sci."},{"key":"65324_CR51","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41592-022-01488-1","volume":"19","author":"M Mirdita","year":"2022","unstructured":"Mirdita, M. et al. ColabFold: Making protein folding accessible to all. Nat. Methods 19, 679\u2013682 (2022).","journal-title":"Nat. Methods"},{"key":"65324_CR52","doi-asserted-by":"publisher","first-page":"W320","DOI":"10.1093\/nar\/gku316","volume":"42","author":"X Robert","year":"2014","unstructured":"Robert, X. & Gouet, P. Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res. 42, W320\u2013W324 (2014).","journal-title":"Nucleic Acids Res."},{"key":"65324_CR53","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/S1046-5928(02)00577-6","volume":"27","author":"KA Foster","year":"2003","unstructured":"Foster, K. A. et al. DNA polymerase III of Enterococcus faecalis: Expression and characterization of recombinant enzymes encoded by the polC and dnaE genes. Protein Expr. Purif. 27, 90\u201397 (2003).","journal-title":"Protein Expr. Purif."},{"key":"65324_CR54","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1002\/2211-5463.13873","volume":"14","author":"A Burt","year":"2024","unstructured":"Burt, A. et al. An image processing pipeline for electron cryo-tomography in RELION-5. FEBS Open Bio 14, 1788\u20131804 (2024).","journal-title":"FEBS Open Bio"},{"key":"65324_CR55","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331\u2013332 (2017).","journal-title":"Nat. Methods"},{"key":"65324_CR56","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jsb.2015.08.008","volume":"192","author":"A Rohou","year":"2015","unstructured":"Rohou, A. & Grigorieff, N. CTFFIND4: Fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 192, 216\u2013221 (2015).","journal-title":"J. Struct. Biol."},{"key":"65324_CR57","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/s41592-019-0575-8","volume":"16","author":"T Bepler","year":"2019","unstructured":"Bepler, T. et al. Positive-unlabeled convolutional neural networks for particle picking in cryo-electron micrographs. Nat. Methods 16, 1153\u20131160 (2019).","journal-title":"Nat. Methods"},{"key":"65324_CR58","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Cryst. D. 66, 486\u2013501 (2010).","journal-title":"Acta Cryst. D."},{"key":"65324_CR59","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Cryst. D. 75, 861\u2013877 (2019).","journal-title":"Acta Cryst. D."},{"key":"65324_CR60","doi-asserted-by":"publisher","DOI":"10.1002\/pro.4792","volume":"32","author":"EC Meng","year":"2023","unstructured":"Meng, E. C. et al. UCSF ChimeraX: Tools for structure building and analysis. Protein Sci. 32, e4792 (2023).","journal-title":"Protein Sci."},{"key":"65324_CR61","doi-asserted-by":"publisher","first-page":"W375","DOI":"10.1093\/nar\/gkm216","volume":"35","author":"IW Davis","year":"2007","unstructured":"Davis, I. W. et al. MolProbity: All-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res 35, W375\u2013W383 (2007).","journal-title":"Nucleic Acids Res"},{"key":"65324_CR62","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"RA Laskowski","year":"2011","unstructured":"Laskowski, R. A. & Swindells, M. B. LigPlot+: Multiple ligand-protein interaction diagrams for drug discovery. J. Chem. Inf. Model 51, 2778\u20132786 (2011).","journal-title":"J. Chem. Inf. Model"},{"key":"65324_CR63","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1021\/ci7001473","volume":"47","author":"AM Clark","year":"2007","unstructured":"Clark, A. M. & Labute, P. 2D depiction of protein-ligand complexes. J. Chem. Inf. Model 47, 1933\u20131944 (2007).","journal-title":"J. Chem. Inf. Model"},{"key":"65324_CR64","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1021\/ci050550m","volume":"46","author":"AM Clark","year":"2006","unstructured":"Clark, A. M., Labute, P. & Santavy, M. 2D structure depiction. J. Chem. Inf. Model 46, 1107\u20131123 (2006).","journal-title":"J. Chem. Inf. Model"},{"key":"65324_CR65","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1021\/acssynbio.6b00104","volume":"5","author":"AM Oliveira Paiva","year":"2016","unstructured":"Oliveira Paiva, A. M., Friggen, A. H., Hossein-Javaheri, S. & Smits, W. K. The signal sequence of the abundant extracellular metalloprotease PPEP-1 can be used to secrete synthetic reporter proteins in Clostridium difficile. ACS Synth. Biol. 5, 1376\u20131382 (2016).","journal-title":"ACS Synth. Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65324-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65324-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65324-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T10:14:36Z","timestamp":1762424076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65324-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["65324"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-65324-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6470547\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"assertion":[{"value":"30 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.U., A.H.F., M.H.L., W.K.S. declare receiving funding from Acurx Pharmaceuticals, Inc for work described in this manuscript. M.H.S., C.J.S., M.R.B., L.I.M. and X.Y. are consultants to Acurx Pharmaceuticals, Inc. R.J.D. is an employee of Acurx Pharmaceuticals, Inc. M.H.S, L.I.M. and X.Y. are shareholders of Acurx Pharmaceuticals, Inc. N.M. declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9784"}}